Safety and Efficacy of 9MW2821 in the Treatment of High-risk Non-muscle-invasive Bladder Cancer (NMIBC)

NCT06551233 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Bladder Cancer

Interventions

DRUG: 9MW2821

Sponsor

The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School